Publications by authors named "Alina Kastner"
Article Synopsis
- There’s a theory that suggests schizophrenia symptoms might get better with medicine that blocks certain dopamine receptors, but not everyone gets better.
- Researchers studied 21 people who were just diagnosed with schizophrenia and hadn’t taken medication before to see how dopamine release affected their symptoms over a year.
- They found that certain areas of the brain releasing more dopamine were linked to improvements in symptoms, helping to understand why some patients respond better to treatment than others.
A growing body of evidence indicates the role of melatonin (MT) in the pathogenesis of multiple sclerosis (MS): It modulates immune function, alleviates oxidative stress and it is linked to seasonality of MS relapse. This report addresses the potential clinical relevance of circadian MT rhythms in relapsing-remitting MS (RRMS) patients. The study sample comprised of fifty-five RRMS patients and fifty age- and sex-matched healthy control (HC) subjects.
View Article and Find Full Text PDF